2'-5' oligoadenylate synthetase 1 polymorphism is associated with prostate cancer.

"FUNDING SOURCES: This work was supported by National Institutes of Health (NIH)/National Center on Minority Health and Health Disparities Grant P20MD002285‐01. The DNA Sequencing Laboratory and the Research Core at Morehouse School of Medicine (Atlanta, Ga) were supported through the Research Centers at Minority Institutions (RCMI) Program (NIH/National Center for Research Resources [NCCR]/RCMI Grant G12‐RR03034). Support for core facilities and shared/additional resources were funded in part by NIH/NCRR/RCMI Grant G12‐RR03062.: CONFLICT OF INTEREST DISCLOSURES: The authors made no financial disclosures."

"FUNDING SOURCES This work was supported by National Institutes of Health (NIH)/National Center on Minority Health and Health Disparities Grant P20MD002285‐01. The DNA Sequencing Laboratory and the Research Core at Morehouse School of Medicine (Atlanta, Ga) were supported through the Research Centers at Minority Institutions (RCMI) Program (NIH/National Center for Research Resources [NCCR]/RCMI Grant G12‐RR03034). Support for core facilities and shared/additional resources were funded in part by NIH/NCRR/RCMI Grant G12‐RR03062. CONFLICT OF INTEREST DISCLOSURES The authors made no financial disclosures."